Clinical Trial Update: 11C-Acetate PET/CT Imaging As a Biomarker of Amyloid-Induced Neuroinflammation [Phase 2]

View source ↗

Summary

Phase 2 trial investigating 11C-Acetate PET/CT imaging as a biomarker of amyloid-induced neuroinflammation in mild cognitive impairment; study terminated with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Snippet

Sponsor: University of Pennsylvania | Conditions: Mild Cognitive Impairment | Phase 2 | Status: TERMINATED | Results posted: 2024-01-11